Showing results (1231-1240 of 1,689) with videos related to

Sort By:
Pageof 169
Circulation. Heart Failure|August 8, 2020
Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval StudyDavid M Shavelle, Akshay S Desai, William T Abraham, et al.
Pediatric Research|June 1, 2000
Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia RegistryP Monagle, M Adams, M Mahoney, et al.
Neuro-Oncology|April 4, 2017
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomasMatthias Holdhoff, Xiaobu Ye, Jeffrey G Supko, et al.
European Heart Journal|May 30, 2015
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patientsAkshay S Desai, John J V McMurray, Milton Packer, et al.
JACC. Heart Failure|July 13, 2020
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF TrialScott D Solomon, Pardeep S Jhund, Brian L Claggett, et al.
JACC. Heart Failure|July 27, 2024
Dynamic Risk Estimation of Adverse Events in Ambulatory LVAD Patients: A MOMENTUM 3 AnalysisPalak Shah, Gabriel Sayer, Shashank S Sinha, et al.
European Journal of Heart Failure|June 27, 2023
Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fractionMingming Yang, Toru Kondo, Carly Adamson, et al.
European Heart Journal|August 2, 2015
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HFPardeep S Jhund, Michael Fu, Edmundo Bayram, et al.
European Journal of Heart Failure|November 17, 2022
Health-related quality of life outcomes in PARAGON-HFAlvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
Cell Host & Microbe|August 28, 2024
Metabolite-based inter-kingdom communication controls intestinal tissue recovery following chemotherapeutic injuryChristopher J Anderson, Laura Boeckaerts, Priscilla Chin, et al.
Pageof 169